Etoposide and Lanoxin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Etoposide (etoposide) and Lanoxin (digoxin). Common drug interactions include hyperglycaemia among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Etoposide and Lanoxin. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

On Jul, 22, 2026

27 people who take Etoposide and Lanoxin together, and have interactions are studied.

Etoposide and Lanoxin drug interactions.

What are the common drug interactions of Etoposide and Lanoxin, by gender? *:

female:

Hyperglycaemia (high blood sugar)
Neutropenia (an abnormally low number of neutrophils)
Blood creatine increased
Blood lactate dehydrogenase increased
Blood pressure decreased
Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Cyst (a closed sac)
Enterococcal bacteraemia (presence of bacteria lactic acid in the blood)
Failure to thrive (inadequate weight gain and physical growth in children)
Hypokalaemia (low potassium)

male:

Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Parkinson's disease
Pneumonia
Respiratory tract infection
Cardiac output decreased
Cardiac tamponade (fluid accumulates in heart covering)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)

What are the common drug interactions of Etoposide and Lanoxin, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Troponin i increased
Adenovirus infection
Alanine aminotransferase increased
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Blood pressure decreased
Blood urea decreased
Brain natriuretic peptide increased
Diarrhoea

20-29:

n/a

30-39:

n/a

40-49:

Alanine aminotransferase increased
Aspartate aminotransferase increased
Cardiac output decreased
Cardiac tamponade (fluid accumulates in heart covering)
Hyperbilirubinaemia (excess of bilirubin in the blood)
Hypotension (abnormally low blood pressure)
Ischaemia (insufficient supply of blood to an organ, usually due to a blocked artery)
Pericardial effusion (fluid around the heart)
Renal failure acute on chronic (rapid or long lasting kidney failure)
Blood pressure systolic inspiratory decreased

50-59:

Abdominal pain
Anaemia (lack of blood)
Chest pain
Dyspnoea (difficult or laboured respiration)
Hypotension (abnormally low blood pressure)
Disease progression

60+:

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Nausea (feeling of having an urge to vomit)
Sepsis (a severe blood infection that can lead to organ failure and death)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Febrile neutropenia (fever with reduced white blood cells)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Lung disorder (lung disease)
Pyrexia (fever)
Renal impairment (severely reduced kidney function)

What are the existing conditions these people have? *

Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 4 people, 14.81%
Nasal Dryness (dry nose): 4 people, 14.81%
Metastatic Neoplasm (spreadable cancer tumour): 3 people, 11.11%
Stress And Anxiety: 2 people, 7.41%
Small Cell Lung Cancer Metastatic (lung cancer spreads to other body parts): 2 people, 7.41%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 2 people, 7.41%
Pain: 2 people, 7.41%
Indigestion: 2 people, 7.41%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 7.41%
High Blood Pressure: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Etoposide and Lanoxin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously